These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3877831)

  • 21. Use of implantable venous access devices in children with severe hemophilia: benefits and burden.
    Van Dijk K; Van Der Bom JG; Bax KN; Van Der Zee DC; Van Den Berg MH
    Haematologica; 2004 Feb; 89(2):189-94. PubMed ID: 15003894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laboratory evidence of DIC under FEIBA treatment of a hemophilic patient with intracranial bleeding and high titre factor VIII inhibitor.
    Fukui H; Fujimura Y; Takahashi Y; Mikami S; Yoshioka A
    Thromb Res; 1981 Apr 1-15; 22(1-2):177-84. PubMed ID: 6794176
    [No Abstract]   [Full Text] [Related]  

  • 23. Current management of hemophilia B.
    Roberts HR; Eberst ME
    Hematol Oncol Clin North Am; 1993 Dec; 7(6):1269-80. PubMed ID: 8294316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intraspinal, extradural hemorrhage in a 7-year-old boy with hemophilia B].
    Jost W; Graf N; Pindur G; Sitzmann FC
    Monatsschr Kinderheilkd; 1990 Jan; 138(1):36-7. PubMed ID: 2314403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Experience from the Hemophilia Clinic. 3. Intramuscular hemorrhages in hemophilia].
    van Creveld S; Mochtar IA; van Donk H
    Ned Tijdschr Geneeskd; 1970 Apr; 114(17):719-22. PubMed ID: 5444639
    [No Abstract]   [Full Text] [Related]  

  • 26. Myocardial infarction during factor IX infusion in hemophilia B: case report and review of the literature.
    Najaf SM; Malik A; Quraishi AU; Kazmi K; Kakepoto GN
    Ann Hematol; 2004 Sep; 83(9):604-7. PubMed ID: 15205916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibodies to factor IX.
    Warrier I
    Haematologica; 2000 Oct; 85(10 Suppl):31-3; discussion 33-4. PubMed ID: 11187867
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of hemophilia B: serendipitous use of continuous infusion coagulation factor IX.
    Goldsmith JC; Gordon EM
    Thromb Res; 1993 May; 70(3):265-7. PubMed ID: 8327991
    [No Abstract]   [Full Text] [Related]  

  • 29. Nonacog gamma, a novel recombinant factor IX with low factor IXa content for treatment and prophylaxis of bleeding episodes.
    Turecek PL; Abbühl B; Tangada SD; Chapman M; Gritsch H; Rottensteiner H; Schrenk G; Mitterer A; Dietrich B; Höllriegl W; Schiviz A; Horling F; Reipert BM; Muchitsch EM; Pavlova BG; Scheiflinger F
    Expert Rev Clin Pharmacol; 2015 Mar; 8(2):163-77. PubMed ID: 25660348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of second-degree burn induced by dry ice in a Christmas disease patient.
    Troccola A; Maruccia M; Zampieri AE; Dessy LA
    Burns; 2010 Sep; 36(6):e115-8. PubMed ID: 20494523
    [No Abstract]   [Full Text] [Related]  

  • 31. [Dental and oral surgical treatment of a B haemophilic patient with high inhibitor level. Case report].
    Vajta L; Nagy Á; Kálovics J; Szalma J
    Fogorv Sz; 2015 Jun; 108(2):61-4. PubMed ID: 26434210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of activated prothrombin complex concentrate in a severely hemophilic patient with Factor VIII inhibitor.
    Garehime WJ; Pecaro BC; Green D
    J Oral Maxillofac Surg; 1983 Apr; 41(4):262-4. PubMed ID: 6220139
    [No Abstract]   [Full Text] [Related]  

  • 33. Immune tolerance induction and the treatment of hemophilia. Malmö protocol update.
    Berntorp E; Astermark J; Carlborg E
    Haematologica; 2000 Oct; 85(10 Suppl):48-50; discussion 50-1. PubMed ID: 11187871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonoperative management of delayed splenic rupture in a patient with hemophilia B.
    Terry NE; Boswell WC
    J Pediatr Surg; 2006 Sep; 41(9):1607-9. PubMed ID: 16952601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute myelogenous leukemia in a patient with severe factor IX deficiency.
    Clark C; Gidvani VK
    Pediatr Blood Cancer; 2011 Jan; 56(1):156-7. PubMed ID: 20842752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of haemophilia B with purified Factor IX (PPSB).
    Loeliger EA; Hensen A; Mattern MJ; Veltkamp JJ; Bruning PF; Hemker HC
    Folia Med Neerl; 1967; 10(4):112-25. PubMed ID: 6073947
    [No Abstract]   [Full Text] [Related]  

  • 37. Occult factor IX deficiency complicating the removal of third molars.
    Allen ML
    J Oral Surg; 1974 May; 32(5):388-90. PubMed ID: 4545281
    [No Abstract]   [Full Text] [Related]  

  • 38. Hemophilia.
    Kashyap R; Choudhry VP
    Indian Pediatr; 2000 Jan; 37(1):45-53. PubMed ID: 10745388
    [No Abstract]   [Full Text] [Related]  

  • 39. Acute alveolar haemorrhage in a patient with haemophilia B.
    Suzuki T; Yamamoto Y; Otaki M; Seita I; Hagiwara T; Amano K; Fukutake K
    Haemophilia; 2012 Jan; 18(1):e29-31. PubMed ID: 22004358
    [No Abstract]   [Full Text] [Related]  

  • 40. [Remote results of the treatment of intracranial hemorrhage in children with congenital hemorrhagic diathesis].
    Klukowska A; Gazda H; Szczepanik E
    Pediatr Pol; 1988 May; 63(5):312-8. PubMed ID: 3217175
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.